Analysing the role of COX-2 in acute oesophagitis and in melatonin-exerted protection against experimental reflux oesophagitis in rats

Journal of Pharmacy and Pharmacology

Volumn 63, Issue 12, 2011, Pages 1572-1580

  Singh, Pratibha ^a   Singh, Neetu ^a   Palit, Gautam ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

acid reflux oesophagitis; COX 2; melatonin; prostaglandin E2

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; MELATONIN; MYELOPEROXIDASE; OMEPRAZOLE; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REFLUX ESOPHAGITIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE LEVEL; WESTERN BLOTTING;

ANIMALS; ANTIOXIDANTS; BLOTTING, WESTERN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; ENZYME ACTIVATION; ESOPHAGITIS; ESOPHAGUS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL HEMORRHAGE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IMMUNOENZYME TECHNIQUES; MELATONIN; MUCOUS MEMBRANE; PEROXIDASE; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 80855135427     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2011.01358.x     Document Type: Article

References (37)

1. Katz PO,. Optimizing medical therapy for gastroesophageal reflux disease: state of the art. Rev Gastroenterol Disord 2003; 3: 59-69. (Pubitemid 36701287)
2. Hamaguchi M, et al,. Increased expression of cytokines and adhesion molecules in rat chronic esophagitis. Digestion 2003; 68: 189-197. (Pubitemid 38250508)
3. Jones DA, et al,. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem 1993; 268: 9049-9054. (Pubitemid 23118701)
4. Zhang F, et al,. Duodenal reflux induces cyclooxygenase-2 in the esophageal mucosa of rats: evidence for involvement of bile acids. Gastroenterology 2001; 121: 1391-1399. (Pubitemid 33140456)
5. Zicari A, et al,. Increased levels of prostaglandins and nitric oxide in esophageal mucosa of children with reflux esophagitis. J Pediatr Gastroenterol Nutr 1998; 26: 194-199. (Pubitemid 28078485)
6. Lanas A, et al,. Selective COX-2 inhibition is associated with decreased mucosal damage induced by acid and pepsin in rabbit esophagitis. Inflammation 2003; 27: 21-29. (Pubitemid 36362009)
7. Mantry P, et al,. Celecoxib associated esophagitis: review of gastrointestinal side effects from cox-2 inhibitors. J Clin Gastroenterol 2003; 37: 61-63. (Pubitemid 36734335)
8. Majka J, et al,. Cyclooxygenase-2 (COX-2) is the key event in pathophysiology of Barrett's esophagus. Lesson from experimental animal model and human subjects. J Physiol Pharmacol 2010; 61: 409-418.
9. Takeuchi K, et al,. Prostaglandin EP receptors involved in modulating gastrointestinal mucosal integrity. J Pharmacol Sci 2010; 114: 248-261.
10. Bubenik GA,. Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci 2002; 47: 2336-2348. (Pubitemid 35205309)
11. Maestroni GJ,. The immunotherapeutic potential of melatonin. Expert Opin Investig Drugs 2001; 10: 467-476. (Pubitemid 32186144)
12. Beyer CE, et al,. Antioxidant properties of melatonin-an emerging mystery. Biochem Pharmacol 1998; 56: 1265-1272. (Pubitemid 28511263)
13. Pereira Rde S,. Regression of gastroesophageal reflux disease symptoms using dietary supplementation with melatonin, vitamins and aminoacids: comparison with omeprazole. J Pineal Res 2006; 41: 195-200.
14. Lahiri S, et al,. Melatonin protects against experimental reflux esophagitis. J Pineal Res 2009; 46: 207-213.
15. Nakamura K, et al,. Effects of sodium polyacrylate (PANa) on acute esophagitis by gastric juice in rats. Jpn J Pharmacol 1982; 32: 445-456. (Pubitemid 12082389)
16. Robert A, et al,. Gastric antisecretory and antiulcer properties of PGE2, 15-methyl PGE2, and 16, 16-dimethyl PGE2. Intravenous, oral and intrajejunal administration. Gastroenterology 1976; 70: 359-370.
17. Hayakawa T, et al,. Roles of cyclooxygenase 2 and microsomal prostaglandin E synthase 1 in rat acid reflux oesophagitis. Gut 2006; 55: 450-456.
18. Brzozowski T, et al,. Effect of local application of growth factors on gastric ulcer healing and mucosal expression of cyclooxygenase-1 and -2. Digestion 2001; 64: 15-29. (Pubitemid 32830548)
19. Grisham MB, et al,. Assessment of leukocyte involvement during ischemia and reperfusion of intestine. Methods Enzymol 1990; 186: 729-742. (Pubitemid 20280020)
20. Bradford MM,. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
21. Hamoui N, et al,. Increased acid exposure in patients with gastroesophageal reflux disease influences cyclooxygenase-2 gene expression in the squamous epithelium of the lower esophagus. Arch Surg 2004; 139: 712-716 discussion 716-717.
22. Murphy JO, et al,. Neither antioxidants nor COX-2 inhibition protect against esophageal inflammation in an experimental model of severe reflux. J Surg Res 2007; 142: 20-27. (Pubitemid 47268008)
23. Northway MG, et al,. Radiation esophagitis in the opossum: radioprotection with indomethacin. Gastroenterology 1980; 78: 883-892. (Pubitemid 10120901)
24. Tjandrawinata RR, et al,. Induction of cyclo-oxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells. Br J Cancer 1997; 75: 1111-1118. (Pubitemid 27140020)
25. Orlando RC,. Pathology of reflux esophagitis and its complications. In:, Jamieson GG, ed. Surgery of the Oesophagus. Edinburgh: Churchill Livingstone, 1988: 189-200.
26. Robbins SL, Cotran RS,. Inflammation and repair. In:, Robbins SL, Cotran RS, eds. Pathologic Basis of Disease, 2nd edn. Philadelphia, PA: WB. Saunders, 1979: 55-90.
27. Takeuchi K, et al,. 16,16-Dimethyl prostaglandin E2 aggravates gastric mucosal injury induced by histamine in rats. Possible role of the increased mucosal vascular permeability. Gastroenterology 1987; 93: 1276-1286. (Pubitemid 17167269)
28. Yamato M, et al,. Biphasic effect of prostaglandin E2 in a rat model of esophagitis mediated by EP1 receptors: relation to pepsin secretion. Digestion 2005; 72: 109-118. (Pubitemid 41507270)
29. Yamaguchi T, et al,. Cytokine-induced neutrophil accumulation in the pathogenesis of acute reflux esophagitis in rats. Int J Mol Med 2005; 16: 71-77.
30. Mayo JC, et al,. Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages. J Neuroimmunol 2005; 165: 139-149. (Pubitemid 40984631)
31. Franchi AM, et al,. Melatonin, 5-methoxytryptamine and some of their analogs as cyclo-oxygenase inhibitors in rat medial basal hypothalamus. Brain Res 1987; 405: 384-388. (Pubitemid 17042832)
32. Deng WG, et al,. Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding. Blood 2006; 108: 518-524.
33. Werbach MR,. Melatonin for the treatment of gastroesophageal reflux disease. Altern Ther Health Med 2008; 14: 54-58.
34. Konturek SJ, et al,. Protective influence of melatonin against acute esophageal lesions involves prostaglandins, nitric oxide and sensory nerves. J Physiol Pharmacol 2007; 58: 361-377. (Pubitemid 47026568)
35. Kawabe A, et al,. Production of prostaglandinE2 via bile acid is enhanced by trypsin and acid in normal human esophageal epithelial cells. Life Sci 2004; 75: 21-34. (Pubitemid 38501762)
36. Kato K, et al,. Central nervous system action of melatonin on gastric acid and pepsin secretion in pylorus-ligated rats. Neuroreport 1998; 9: 3989-3992. (Pubitemid 29189339)
37. Chuang JI, et al,. Effect of melatonin on NF-kappa-B DNA-binding activity in the rat spleen. Cell Biol Int 1996; 20: 687-692.